SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-018448
Filing Date
2019-06-27
Accepted
2019-06-27 18:05:19
Documents
2
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 12584
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4466
  Complete submission text file 0000899243-19-018448.txt   18485
Mailing Address C/O EXELIXIS INC 170 HARBOR WAY S SAN FRANCISCO CA 94083-0511
Business Address
MCCORMICK FRANK (Reporting) CIK: 0001257809 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38959 | Film No.: 19926650

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences